Garrick Johnson
Physician Assistant · Concord, NHNPI 1891711156
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,955 of the $4,021 with a category attached, or 73.5%. It is spread thinly across 20 manufacturers, the largest accounting for just 17.9%. Reporting peaked in 2024 at $1,795 and has fallen 57.6% since, to $760 in 2025. Among physician assistant clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $61.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$720
- Johnson & Johnson$713
- AstraZeneca$480
- E.r. Squibb & Sons, L.L.C.$378
- Daiichi Sankyo Inc.$281
- Takeda Pharmaceuticals U.S.A., Inc.$266
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$72018%
- Food & beverage$2,95573%
- Education$3479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $720 |
| Johnson & Johnson | 8 | $713 |
| AstraZeneca | 7 | $480 |
| E.r. Squibb & Sons, L.L.C. | 4 | $378 |
| Daiichi Sankyo Inc. | 6 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $266 |
| Novartis | 7 | $204 |
| AbbVie | 3 | $190 |
| Seagen Inc. | 2 | $141 |
| Jazz Pharmaceuticals Inc. | 1 | $137 |
| Pfizer | 2 | $115 |
| Astellas Pharma US Inc | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| Bristol Myers Squibb | 4 | $74 |
| Karyopharm Therapeutics Inc. | 2 | $43 |
| Eisai Inc. | 1 | $20 |
| GSK | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Taiho Oncology, Inc. | 1 | $15 |
| Novocure Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,021 in reported general payments places this provider in the 95th percentile of 782 physician assistant providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 75 | $1,190,060 |
| PomalystPomalidomide | 42 | $834,216 |
| Lenalidomide | 65 | $823,064 |
| JakafiRuxolitinib Phosphate | 29 | $426,139 |
| CalquenceAcalabrutinib Maleate | 26 | $378,729 |
| ImbruvicaIbrutinib | 21 | $335,521 |
| IbrancePalbociclib | 21 | $319,654 |
| BosulifBosutinib | 13 | $267,494 |
| GilotrifAfatinib Dimaleate | 14 | $155,276 |
| Abiraterone Acetate | 22 | $72,780 |
| EliquisApixaban | 95 | $67,913 |
| PegasysPeginterferon Alfa-2a | 12 | $53,647 |
| Budesonide ErBudesonide | 11 | $5,568 |
| Acyclovir | 57 | $1,417 |
| Potassium Chloride | 80 | $1,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $74 | $1,190,06075 claims |
| E.r. Squibb & Sons, L.L.C.Pomalyst | $378 | $834,21642 claims |
| PfizerIbrance, Bosulif, Eliquis | $115 | $655,061129 claims |
| AstraZenecaCalquence | $480 | $378,72926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 782 physician assistant providers in New Hampshire.
Other physician assistant in Concord
- Lindsay OverkoConcord$29K
- Zoe NikitasConcord$6K
- Alicia SloanConcord$4K
- Sheli TinkelmanConcord$3K
- Bernard MacgregorConcord$3K
- Sara CarrierConcord$2K
- Katelyn WatsonConcord$2K
- Joseph ZucchiSalem$40K
- Evelyn SteinPortsmouth$26K
- Shari AshtonManchester$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.